SignatureFD’s Agilon Health AGL Stock Holding History

SignatureFD’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-25	Closed	-$424	–	3468
2025 Q4	$424	Sell	25 -414	-94%	-$8.03K	﹤0.01%	3248
2025 Q3	$11.3K	Sell	439 -780	-64%	-$29.5K	﹤0.01%	2364
2025 Q2	$70.1K	Buy	1,219 +481	+65%	+$38.6K	﹤0.01%	1411
2025 Q1	$79.9K	Buy	738 +162	+28%	+$14.1K	﹤0.01%	1324
2024 Q4	$27.3K	Buy	576 +339	+143%	+$20.5K	﹤0.01%	1904
2024 Q3	$23.3K	Sell	237 -237	-50%	-$30.6K	﹤0.01%	1966
2024 Q2	$77.5K	Buy	474 +296	+166%	+$42.2K	﹤0.01%	1292
2024 Q1	$27.1K	Buy	178 +174	+4,350%	+$29K	﹤0.01%	1848
2023 Q4	$1.19K	Sell	4 -63	-94%	-$22.8K	﹤0.01%	2881
2023 Q3	$29.7K	Buy	67 +28	+72%	+$12.7K	﹤0.01%	1641
2023 Q2	$16.7K	Sell	39 -7	-15%	-$3.93K	﹤0.01%	1980
2023 Q1	$27.2K	Buy	46 +17	+59%	+$9.52K	﹤0.01%	1699
2022 Q4	$11.7K	Buy	29 +23	+383%	+$10.8K	﹤0.01%	2074
2022 Q3	$3K	Buy	+6	New	+$3.59K	﹤0.01%	2599
2022 Q1	–	Sell	-2	Closed	-$1K	–	3124
2021 Q4	$1K	Buy	+2	New	+$1.22K	﹤0.01%	2858

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

SignatureFD's AGL Position: Q1 2026 in Review

SignatureFD sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 25 shares — an estimated $424 sold.

SignatureFD first reported a position in AGL in Q4 2021 and held it in 15 quarters. The position peaked at $79.9K in Q1 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

SignatureFD reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
SignatureFD sold 25 Agilon Health shares in Q1 2026, an estimated $424.
SignatureFD first reported a position in Agilon Health in Q4 2021 and held it in 15 quarters.
SignatureFD's Agilon Health position peaked at $79.9K in Q1 2025.
97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.